Related Experiment Video
Updated: Apr 3, 2026

The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits
Published on: August 20, 2014
Performance of chemically modified plastic blood collection tubes
Raffick A R Bowen1, Samuel C Kim2, Annie Sattayapiwat1
1Clinical Chemistry Service, Department of Pathology, Stanford University Medical Center, Rm H1507B, Stanford, CA 94305-5627, United States.
Newly developed chemoPET blood collection tubes (BCTs) showed no significant differences in analyte concentrations compared to traditional glass tubes. These surfactant-free tubes are a viable alternative for clinical chemistry and hormone analysis.
Area of Science:
- Clinical Chemistry
- Analytical Biochemistry
- Materials Science
Background:
- Commercially available serum blood collection tubes (BCTs) often contain surfactants that can interfere with specific clinical assays.
- The development of alternative BCTs free from problematic surfactants is crucial for accurate diagnostic testing.
Purpose of the Study:
- To evaluate the performance of novel chemoPET blood collection tubes (BCTs) against standard glass tubes and other commercial BCTs.
- To assess the suitability of chemoPET tubes for analyzing cortisol, total triiodothyronine (TT3), total thyroxine (TT4), and routine clinical chemistry analytes.
Main Methods:
- Blood specimens from 60 healthy volunteers and pooled quality control (QC) materials were analyzed.
- Analyte concentrations were measured using Immulite 1000 and Siemens RxL instruments.
- Statistical analysis (t-tests, ANOVA) and bias assessment against glass tubes were performed.
Main Results:
- No statistically or clinically significant differences were observed in analyte concentrations between chemoPET tubes and other BCTs, including glass tubes.
- Analyte concentrations in chemoPET tubes remained within acceptable bias limits derived from biological variation.
Conclusions:
- The modified and aged chemoPET tubes, lacking problematic surfactants, are a suitable alternative to conventional serum BCTs.
- These tubes minimize interference issues encountered with certain clinical assays on specific analytical platforms.
More Related Videos
11:12Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs
Published on: March 9, 2013
09:41Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020